Elevate your net zero performance. Our sustainability bureau leverages our unique 3C approach to deliver optimal sustainability performance across all of your life science sites.
Are you part of a life science organisation committed to a decarbonisation target due in the next decade or so?
If so, you’re certainly not alone.
As an industry, pharma has been a leading voice on the topic of sustainability for many years. In fact, the net zero ambitions of many of the world’s largest life science organisations have demonstrated a greater hunger for a low carbon future than the majority of UN-member countries.
In spite of this admirable ambition, many pharma companies are still lacking a comprehensive plan for delivering net zero.
Much of the technology and knowledge required to deliver a low-carbon future already exist, but piecing this together requires a deep understanding of the unique sustainability challenges within the life science industry.
Optimise your operations on a global scale through the creation of a net zero roadmap via our Sustainability Bureau.
Our roadmaps not only demonstrate the pathway to zero emissions, but also identify key decision points along the way and signpost any emerging technologies ripe for scalable implementation.
We fully quantify your journey to zero, leveraging our 3C approach and decades of experience in pharmaceutical facilities to understand the cost, carbon and compliance impact of a zero carbon future on your business.
For one organisation, our roadmap identified a 12 year pathway complete with 60,000 tonnes of CO2 reduction per year, while simultaneously providing a 15 year operational cost reduction of $376m – enabling our life science client to accelerate their net zero ambition.